Free Trial
NASDAQ:MEDS

Wellgistics Health Q2 2026 Earnings Results & Report

Wellgistics Health logo
$3.02 -0.38 (-11.18%)
As of 12:32 PM Eastern

Wellgistics Health reported Q2 2026 earnings on August 17, 2026. The company reported EPS of -$7.13, while revenue was $1.78 million.

Earnings Announcement Details

Quarter
Q2 2026
Report Date
Time
Before Market Opens

Wellgistics Health EPS Results

Actual EPS
-$7.13
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Wellgistics Health Revenue Results

Actual Revenue
$1.78 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Wellgistics Health Q2 2026 Earnings FAQ

Wellgistics Health (NASDAQ:MEDS) reported earnings of -$7.13 per share for Q2 2026. The report was announced on Monday, August 17, 2026.

Wellgistics Health reported revenue of $1.78 million for Q2 2026.

Wellgistics Health Earnings Headlines

Best Penny Stocks To Follow Today - September 28th
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.tc pixel
See More Wellgistics Health Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Wellgistics Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Wellgistics Health and other key companies, straight to your email.

About Wellgistics Health

Wellgistics Health (NASDAQ:MEDS) is a healthcare technology and pharmaceutical distribution company focused on improving access to prescription medications. The company connects pharmaceutical manufacturers, wholesalers, pharmacies, healthcare providers and patients through technology-enabled services designed to support the movement and dispensing of medications.

Its business includes pharmaceutical distribution and related supply-chain solutions, with an emphasis on helping pharmacies and healthcare organizations source and manage prescription products. Wellgistics also develops digital infrastructure intended to streamline ordering, fulfillment, communication and other operational processes across the medication supply chain.

The company primarily serves participants in the U.S. healthcare and pharmaceutical markets. Publicly available information about its detailed operating history and leadership is limited, and the company’s services and strategic focus may continue to evolve as it expands its healthcare technology platform.

View Wellgistics Health Profile